Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 15;227(12):1376-1380.
doi: 10.1093/infdis/jiad039.

Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy

Collaborators, Affiliations

Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy

Rajesh T Gandhi et al. J Infect Dis. .

Abstract

Fourteen people with human immunodeficiency virus type 1 had longitudinal measurements of intact, defective, and total proviral DNA over the course of two decades of antiretroviral therapy. Three patterns of intact proviral DNA decay were revealed: (1) biphasic decline with markedly slower second-phase decline, (2) initial decline that transitions to a zero-slope plateau, and (3) initial decline followed by later increases in intact proviral DNA. Defective proviral DNA levels were essentially stable. Mechanisms of slowing or reversal of second-phase decay of intact proviral DNA may include the inability to clear cells with intact but transcriptionally silent proviruses and clonal expansion of cells with intact proviruses.

Keywords: HIV; antiretroviral therapy; intact proviruses; reservoirs.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. G. M. L. and A. M. are employees of and equity holders in Accelevir Diagnostics, a for-profit entity. S. A. R. has received funding to her institution from Gilead Sciences and Merck for a clinical trial. K. R. is an employee of Accelevir Diagnostics, a for-profit entity. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Examples of decay patterns in intact proviral DNA (IPD) for participants on long-term antiretroviral therapy (ART). A, Five participants had a similar pattern with slowing decay of intact proviruses during the second decade of ART. B, Three participants showed plateauing of decay (second phase slope effectively zero). C, Two participants had patterns of late increases. Abbreviation: NA, not applicable.

Similar articles

Cited by

References

    1. Bruner KM, Wang Z, Simonetti FR, et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 2019; 566:120–5. - PMC - PubMed
    1. Falcinelli SD, Kilpatrick KW, Read J, et al. Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of individuals receiving antiretroviral therapy. J Infect Dis 2021; 224:92–100. - PMC - PubMed
    1. Bosch RJ, Gandhi RT, Mar H, et al. Associations between multiple measures of HIV-1 persistence in persons on suppressive antiretroviral therapy. J Infect Dis 2022; 225:2163–6. - PMC - PubMed
    1. Antar AAR, Jenike KM, Jang S, et al. Longitudinal study reveals HIV-1–infected CD4+ T cell dynamics during long-term antiretroviral therapy. J Clin Invest 2020; 130:3543–59. - PMC - PubMed
    1. Gandhi RT, Cyktor JC, Bosch RJ, et al. Selective decay of intact HIV-1 proviral DNA on antiretroviral therapy. J Infect Dis 2021; 223:225–33. - PMC - PubMed

Publication types